Brain Cancer
Cerebral Glioblastoma
Female, 42 years
Patient Internal 103598333
ICD-10 code
C71.8 Malignant Neoplasm of Overlapping Sites of Brain
Diagnosis (Incl. Metastases/Stage) and Year
February 2021
Glioblastoma (WHO grade IV), IDH(-), TERT(-), MGMT(+), Chromosome 7 Trisomy and Chromosome 10 Monosomy, BRAF(-).
Previous Treatment
Radiation Therapy, Chemotherapy (Temozolomide + Lomustine).
Prognosis and Survival Expectation
The prognosis remains poor, with a median survival of ~ 14 months from diagnosis.
Treatment Provided
Autologous DCV (5 doses) and CIK (4doses) over a period of 3 months.
Patient Survival/Condition and Year
Date of Review: 15/10/2023
The patient has survived 18 months from the diagnosis. It can be concluded that Immunotherapy, alongside Radiation Therapy and Chemotherapy, has extended the patient’s survival by 4 months over the median survival.
